Testing a flu or COVID vaccine response in people with lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study checks how your immune system responds after getting a vaccine. It focuses on people with different types of lymphoma, aiming to learn which immune responses can be measured and whether the vaccines are safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of lymphoma in a listed group (B-NHL, CLL, MCL, or aggressive PTCL)
- You meet timing rules based on your recent chemotherapy or ongoing medicine (for example, certain chemo time windows or starting ibrutinib at least 1 month ago)
- You can sign consent and understand the study plan, and you can attend all study visits
- You did not get the current-season flu vaccine (and you don’t seem to have flu right now), and your blood counts are within study limits
- For some groups (cohort 3), you must have had at least 1 COVID-19 vaccine dose before (unless you have not had one, in which case you may still qualify)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational vaccine (Oncoquest-L) in people with newly diagnosed, advanced follicular lymphoma that is not causing symptoms. The goal is to see whether the vaccine can help the immune system control the cancer without needing immediate intensive treatment.
This study looks at how well vaccines work in people with multiple myeloma or certain lymphomas after they receive CAR-T cell therapy. It aims to help doctors understand the best way to revaccinate patients to protect against preventable diseases.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
This trial tests how well the flu vaccine works in people with blood cancers like lymphoma, leukemia, or multiple myeloma. It aims to find the best vaccination strategy to protect you during treatment.
This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.